TRA-1-85/CD147 Antibody (TRA-1-85) [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3195CL1
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Description
CoraFluor(TM) 1, amine reactive
CoraFluor(TM) 1, thiol reactive
For more information, please see our CoraFluor(TM) TR-FRET technology flyer.
Scientific Data Images for TRA-1-85/CD147 Antibody (TRA-1-85) [CoraFluor™ 1]
Product Feature: CoraFluor Probes for TR-FRET
CoraFluor™ 1, amine reactive (Catalog:7920) and CoraFluor™ 2, amine reactive (Catalog # 7950) are terbium-based probes that have been developed for use as TR-FRET donors. They emit wavelengths compatible with commonly used fluorescent acceptor dyes such as BODIPY® (or BDY) and Janelia Fluor® dyes, FITC (Catalog # 5440), TMR and Cyanine 5 (Catalog # 5436). CoraFluor™ fluorescence is brighter and more stable in biological media than existing TR-FRET donors, leading to enhanced sensitivity and improved data generation. CoraFluor™ 1 exhibits excitation upon exposure to a 337 nm UV laser.Applications for TRA-1-85/CD147 Antibody (TRA-1-85) [CoraFluor™ 1]
CyTOF-ready
Flow Cytometry
Immunocytochemistry
Knockout Validated
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: TRA-1-85/CD147
The TRA-1-85 antigen, also known as OKa blood group antigen, is a specific epitope within the protein known as basigin, EMMPRIN, or CD147. It is a cell surface determinant expressed on almost all human cell types. Antibodies to TRA-1-85 have been used in somatic cell hybrid or transplantation studies to identify tissues containing cells of human origin.
Alternate Names
Gene Symbol
Additional TRA-1-85/CD147 Products
Product Documents for TRA-1-85/CD147 Antibody (TRA-1-85) [CoraFluor™ 1]
Product Specific Notices for TRA-1-85/CD147 Antibody (TRA-1-85) [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.